(Adds Outlook)
Zimmer Biomet Holdings, Inc. (ZBH) updated full-year 2024 financial guidance to reduce and narrow previous projected ranges for revenue growth and adjusted EPS. Adjusted EPS is now expected in a range of $7.95 - $8.05, revised from prior guidance range of $8.00 - $8.15. Reported revenue is anticipated to rise 3.5% - 4.0%, updated from previous guidance range of 4.0% - 5.0%.
Q3 Results:
The company's earnings came in at $249.1 million, or $1.23 per share. This compares with $162.7 million, or $0.77 per share, in last year's third quarter. Excluding items, adjusted earnings was $1.74 per share compared to $1.65. Analysts on average had expected the company to earn $1.73 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items. The company's revenue for the quarter rose 4.1% to $1.82 billion from $1.75 billion last year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.